Skip to main content
. 2016 Feb 18;2016(2):CD007874. doi: 10.1002/14651858.CD007874.pub2

McCluskey 2003.

Methods Randomized controlled trial
Participants Age (years, mean ± SD): Control group = 36.7 ± 11.3, EMLA group = 37.1 ± 11.2, Lidocaine group = 41.4 ± 10.7
Gender (M:F): 100% female
Inclusion criteria: Age 18 years to70 years old, ASA I‐II, gynaecological day case‐surgery
Exclusion criteria: N/A
Recruitment: 90 adult patients randomly assigned (30 in each group)
Setting: United Kingdom
Interventions Admixture
Control group: placebo cream applied over a wide area to the dorsum of the nondominant hand and distal forearm 60 min before surgery and anaesthesia induced with 18 ml of 1% propofol (Diprivan®) mixed with 2 ml of 0.9% saline
EMLA group: EMLA cream applied as described above and anaesthesia induced with 18 ml of 1% propofol mixed with 2 ml of 0.9% saline
Lidocaine group: placebo cream applied as described above and anaesthesia induced with 18 ml of 1% propofol premixed with 2 ml of 2% lidocaine (40 mg).
Outcomes Pain intensity assessed on 4‐point scale
0 = no pain
1 = mild pain
2 = moderate pain
3 = severe pain
Outcomes reported and used
  1. Incidence of high‐intensity pain

  2. Incidence of pain


Outcomes sought but not reported
  1. Adverse effects

  2. Patient satisfaction

Notes Period of the study: dates not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk N/A
Allocation concealment (selection bias) Low risk "The patients were randomly allocated by sealed envelope into three groups."
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk N/A
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk "The nurses who insert IV cannula were the investigator assessing pain on propofol injection".
Possible bias as nurses might suspect patient had had EMLA if they did not have pain when IV cannula inserted. However, the nurses would not know whether patient was in control or lidocaine group which were the groups whose results we analysed.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No withdrawals
Selective reporting (reporting bias) Unclear risk N/A
Other bias Low risk The study appears to be free of other sources of bias